SK Biopharm Signs Pharmaceutical Supply Contract Worth 11.3 Billion KRW
[Asia Economy Reporter Park Jihwan] SK Biopharm announced on the 25th that it has signed a pharmaceutical supply contract worth 11.3 billion KRW with its subsidiary SK Life Science.
Hot Picks Today
![[Breaking] "Management to Defer Allocation Method for Deficit Business Units by One Year"](https://cwcontent.asiae.co.kr/asiaresize/93/2026052014513970767_1779256299.png)
[Breaking] "Management to Defer Allocation Method for Deficit Business Units by One Year"
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The contract amount corresponds to 43.51% of recent sales revenue.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
